3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Urothelial Carcinoma of the Bladder
1
Squamous Cell Carcinoma of Head and Neck
1
Non-Muscle Invasive Bladder Urothelial Carcinoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Laryngeal Neoplasms
1
Ganglioneuroblastoma
1
Carcinoma
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
13
Rituximab
11
Prednisone
9
Vincristine
8
Lenalidomide
8
Doxorubicin
8
Bendamustine Hydrochloride
7
obinutuzumab
5
fludarabine
4
Whole-Body Irradiation
4
Magnetic Resonance Spectroscopy
4
Specimen Handling
3
R-CHOP protocol
3
Prednisolone
3
Peripheral Blood Stem Cell Transplantation
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
fludarabine phosphate
2
Radiotherapy
2
Oxaliplatin
2
Mycophenolic Acid
2
Melphalan
2
Gemcitabine
2
Etoposide
2
Cytarabine
2
venetoclax
1
umbralisib
1
treosulfan
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Follicular
×
Transurethral Resection of Bladder
×
30 days
×
Clear all
No trials found.